Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Sinem, Namdaroglu"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S51-S52 (2021)
Objective: Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder that can be especially seen in children and young adults. The clinical presentation of patients with LCH varies according to the sites of involvement. In about half of pati
Externí odkaz:
https://doaj.org/article/846014ba5b5945e6a8bbf73315f12edd
Autor:
Serife Solmaz Medeni, Sinem Namdaroglu, Tugba Cetintepe, Can Ozlu, Funda Tasli, Zehra Hilal Adibelli, Oktay Bilgir, Erhan Tatar
Publikováno v:
Hematology Reports, Vol 10, Iss 3 (2018)
Atypical hemolytic uremic syndrome is a rare and progressive disease caused by uncontrolled alternative complement activation. Dysregulatıon of the complement activation results in thrombotic microangiopathy and multiorgan damage. A 29-yearold woman
Externí odkaz:
https://doaj.org/article/ec9aa86a703d4044a653635465b25f3c
Publikováno v:
Journal of Phlebology & Lymphology. 2020, Vol. 13 Issue 1, p12-16. 5p.
Autor:
Mehmet Ali Erkurt, Mustafa Mahir Ulgu, Tuba Hacibekiroglu, Serdal Korkmaz, Mehmet Sinan Dal, Osman Celik, Kursat Dal, Sinem Namdaroglu, Tuğçe Nur Yiğenoğlu, Suayip Birinci, Ilhami Berber, Naim Ata, Abdulkadir Basturk, Semih Başcı, Mehmet Hilmi Dogu, Burhan Turgut, Fevzi Altuntaş
Publikováno v:
Internal and Emergency Medicine
Previous studies reported that COVID-19 patients with cancer had higher rates of severe events such as intensive care unit (ICU) admission, mechanical ventilation (MV) assistance, and death during the COVID-19 course compared to the general populatio
Autor:
Duzgun Ozatli, Aslı Odabaşı Giden, Mehmet Ali Erkurt, Serdal Korkmaz, Semih Basci, Turgay Ulas, Burhan Turgut, Tugce Nur Yigenoglu, Tuba Hacibekiroglu, Abdulkadir Basturk, Mehmet Sinan Dal, Sinem Namdaroglu, Fehmi Hindilerden, Sibel Kabukcu Hacioglu, Gulsum Akgun Cagliyan, Gul Ilhan, Murat Kacmaz, Ayşe Uysal, Mustafa Merter, Omer Ekinci, Fadime Ersoy Dursun, Atakan Tekinalp, Sinan Demircioglu, Gulden Sincan, Didar Yanardag Acik, Aydan Akdeniz, Mehmet Ali Ucar, Mahmut Yeral, Rafiye Ciftciler, Hava Uskudar Teke, Elif Gulsum Umit, Abdullah Karakus, Yusuf Bilen, Osman Yokus, Murat Albayrak, Cengiz Demir, Vahap Okan, Songül Serefhanoglu, Sami Kartı, Zubeyde Nur Ozkurt, Bulent Eser, Ismet Aydogdu, Irfan Kuku, Seckin Cagirgan, Mehmet Sonmez, Gulsum Ozet, Fevzi Altuntas
Publikováno v:
Transfusion and Apheresis Science. 62:103662
Autor:
Mustafa Merter, Mehmet Hilmi Dogu, Mehmet Ali Erkurt, Ahmet Sarici, Abdulkadir Basturk, Sinan Demircioğlu, Turgay Ulas, Serdal Korkmaz, Düzgün Özatlı, Buğra Sağlam, Metin Bagci, Fevzi Altuntaş, Tuba Hacibekiroglu, Jale Yıldız, Emine Gültürk, Fehmi Hindilerden, Bülent Eser, Mehmet Sinan Dal, Sinem Namdaroglu, Omer Ekinci
Publikováno v:
Journal of Pharmaceutical Research International. :92-98
Objective: Pomalidomide is a new generation thalidomide analogue. Effectiveness as a single agent or combination with low dose dexamethasone has been in the treatment of relapse/refractory Multiple Myeloma (MM). The aim of the present study was to sh
Publikováno v:
Indian Journal of Otolaryngology and Head & Neck Surgery. 74:6075-6077
Granulocytic sarcoma (GS) is a malignancy of the bone marrow precursor cells, often associated with acute or chronic myeloid leukemia, forming isolated masses with extramedullary spread. It rarely shows laryngeal involvement. In this case report, a c
Autor:
Erhan Tatar, Kerime Rumeysa Sari, Guliz Ozkok, Merve Aktar, Bulent Vatansever, Sinem Namdaroglu, Merve Soyhan
Publikováno v:
Turkish Journal of Nephrology. 30:176-178
Autor:
Tuba Hacibekiroglu, Suayip Birinci, Ilhami Berber, Mustafa Okan Ayvalı, Mehmet Ali Erkurt, Murat Caglayan, Kursat Dal, Naim Ata, Osman Celik, Fevzi Altuntaş, Mehmet Sinan Dal, Sinem Namdaroglu, Mustafa Mahir Ulgu, Mehmet Hilmi Dogu, Burhan Turgut, Tuğçe Nur Yiğenoğlu, Abdulkadir Basturk, Semih Başcı, Serdal Korkmaz
Publikováno v:
Journal of Oncology Pharmacy Practice
Introduction In this study, we aim to report the outcome of COVID-19 in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitor (TKI). Method The data of 16 laboratory-confirmed COVID-19 patients with CML receiving TKI and age, ge
Publikováno v:
International Journal of Hepatology & Gastroenterology. 6:010-017